NEW YORK,, March 20, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against agilon health, inc. ("agilon" or the "Company") (NYSE:AGL) in the United States District Court for the Western District of Texas on behalf of all persons and entities who purchased or otherwise acquired agilon securities between Agilon common stock pursuant, or traceable, or both, to materials issued in connection with the Company's secondary public offering (the "SPO Materials") that occurred on or about May 16, 2023; and/or between January 9, 2023 and January 4, 2024, both dates inclusive (the "Class Period"). Investors have until May 20, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
Click here to participate in the action.
Agilon, headquartered in Austin, Texas, generates profits from reducing medical expenditures. By partnering primarily with Medicare Advantage ("MA") plans as well as traditional Medicare and commercial managed care organizations, agilon receives a fixed monthly payment from payers for each patient under its care. In return, agilon takes on the responsibility of managing the total ...